Atlas Trials

Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD

Clinical trial NCT02502981 · UNKNOWN

Trial details

NCT number
NCT02502981
Sponsor
University Hospital Birmingham
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Renal Insufficiency, ChronicCardio-Renal Syndrome
Start date
2014-06-01
Primary completion
2018-02-01
Enrollment
154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.